Velsera and Diagnostica Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
News
On September 16, 2024 | By The Velsera Clinical and Compliance Team
Velsera Technology Paves the Way for Advanced Cancer Diagnostics with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD
Read more
Blog
On July 23, 2024 | By The Velsera Clinical and Compliance Team
Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2
Read more
Blog
On July 9, 2024 | By The Velsera Clinical and Compliance Team
Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You
Read more
News
On June 28, 2024 | By The Velsera Clinical and Compliance Team
Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey
Read more
News
On June 27, 2024 | By The Velsera Clinical and Compliance Team
Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus
Read more
Blog
On June 20, 2024 | By The Velsera Clinical and Compliance Team
Navigating your molecular lab’s test selection and development over the next two years
Read more
News
On June 3, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show
Read more
Blog
On May 14, 2024 | By The Velsera Clinical and Compliance Team
Four Years, Five Stages: the FDA’s Final Rule on LDTs
Read more
News
On April 4, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research
Read more
News
On March 5, 2024 | By The Velsera Clinical and Compliance Team
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Read more
News
On November 15, 2023 | By The Velsera Clinical and Compliance Team
Faster, smarter clinical interpretation workflows unveiled on CGW platform
Read more